Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.1600T>G | p.Cys534Gly | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TGT | Cys | GGT | Gly | T->G | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #04 | Disulfide bonds 534-546 (C1) | No | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): none Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
0.67 | 0.00 (pathogenous) | 100 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
FRA01BOU F0663 I0700 | Proband | Female | NA | FRANCE |
Phenotypic group | Disease |
NA | MFS |
Symptom |
Reference ID | PubMed ID | Reference |
207 | - | Boileau C. (personnal communication 2013) |